Development and validation of a multimodal feature fusion-based model for predicting postoperative recurrence-free survival in locally advanced laryngeal squamous cell carcinoma.

Front Oncol · 2025 · PMC12507578 · PMID 41079120

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

did not reach statistical significancep = 0.079so close (0.05 < p ≤ 0.1)

Although the IDI gain did not reach statistical significance (p = 0.079), it transcended the minimal clinically important difference (MCID = 5%) ( 31 ) and thus, might have potential value.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.